Deciphera Pharmaceuticals is a clinical-stage biopharmaceutical company that develops medicines for patients with cancer. It utilizes its drug discovery platform and designs kinase inhibitors. The pipeline includes ripretinib, vimseltinib, rebastinib, and DCC-3116.